Aster DM Healthcare, Dubai, and XLRI Jamshedpur sign MoU

Aster DM Healthcare, Dubai, and XLRI Jamshedpur sign MoU

India Pharma Outlook Team | Thursday, 23 October 2025

 Aster

Xavier?‍?‌‍?‍‌?‍?‌‍?‍‌ School of Management, Jamshedpur, was the venue of a distinguished leadership session with Jacob Jacob, Group Chief Human Resources Officer of Aster DM Healthcare, Dubai, as part of the Aster NextGen Management Trainee Program.

The key-note of the session was “Catalyst of Business Growth: The New Dimensions of Technology and People,” It was a very enlightening session as it was the first time the how technology and human capital together form the future of business transformation and leadership effectiveness was shared in such a convincing manner.

An exciting moment in the event was the equally historic Memorandum of Understanding (MoU) signing witnessed by Aster DM Healthcare, Dubai, and XLRI Jamshedpur, representing the commencement of a partnership enterprise that connects the academic world with the industry.

Dr.(Fr.) Sebastian George, S.J., Director of XLRI Jamshedpur; Prof. Kanagraj Ayyaluswamy, Convenor of Corporate Relations and Placement; Prof. Sunil Sarangi, Co-convener; Prof. Giridhar Ramachandran, Associate Dean – XLRI Online Learning; Rajni Ranjan and Ashish Pal, Vice Presidents of Corporate Relations and Placements at XLRI were the dignitaries who witnessed the event.

Also Read: Superhealth, United Imaging in 2,500 Cr Radiology Deal

With Jacob Jacob and Shahed Abdul Rahiman, Head of HR Corporate & Aster Digital Health, were attended by four senior leaders from Aster DM Healthcare, Dubai: Manish Singh, Assistant General Manager, Performance and Rewards; Ms. Febina Abdul Rahiman, Deputy Manager, Talent Acquisition and Human Resources.

The trio of Manish, Febina, and Jacob alongside other members of the Aster HR team used the presence of the market leaders and educators to provide insights on performance & rewards, digital & talent acquisition, and HR.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.